| Financial Year |
March 31 2023 |
| Monetary Funds |
867,873,476.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
191,578,167.08 |
| Accounts Receivable |
4,060,360,289.37 |
| Advances to Suppliers |
408,863,490.92 |
| Other Receivables |
132,360,757.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,978,821,844.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
21,512,410.03 |
| Total Current Assets |
11,603,713,758.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
834,130,115.17 |
| Investment Properties |
-- |
| Fixed Assetes |
3,968,046,508.85 |
| Under-construction Projects |
198,509,535.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
906,405,376.88 |
| R&D expenses |
-- |
| Goodwill |
645,742,972.74 |
| Long-Term Deferred and Prepaid Expenses |
36,360,089.62 |
| Deferred Income Tax Assets |
212,650,130.00 |
| Other Non-Current Assets |
238,781,977.83 |
| Sub-Total of Non-Current Assets |
7,622,462,129.12 |
| Total Assets |
19,226,175,887.12 |
| Short-Term Loans |
1,003,396,302.61 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,555,495,156.30 |
| Accounts Payable |
2,793,956,751.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
122,959,763.74 |
| Taxes Payable |
38,652,851.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
227,589,677.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
679,943,290.19 |
| Other Current Liabilities |
306,785,299.21 |
| Sub-Total of Current Liabilities |
9,171,686,414.35 |
| Long-term Loans |
1,507,386,611.12 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,979,519.90 |
| Deferred Income Tax Liabilities |
41,133,907.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,112,368,822.09 |
| Total Liabilities |
11,284,055,236.44 |
| Paid-In Capital(Or Share Stock) |
4,339,419,293.00 |
| Capital Surplus |
2,101,440,516.92 |
| Surplus Reserve |
904,738,140.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
463,199,828.97 |
| Minority Stockholder's Interest |
219,676,729.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,722,443,920.90 |
| Owner's Equity（Stockholder's Equity） |
7,942,120,650.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,226,175,887.12 |
